January 6, 2009 - LightLab Imaging Inc. said the number of clinical intravascular optical coherence tomography (OCT) procedures using the company's OCT systems has surpassed 10,000.
OCT is a new high-resolution, high-speed imaging modality that uses advanced photonics for intravascular imaging and tissue characterization for diagnosis and treatment of coronary artery disease.
With a 10-fold higher resolution than intravascular ultrasound, the company believes OCT is poised to become the gold standard imaging modality when high-resolution images are essential. Light Lab's systems, the 300 M2 and M2x, are in use in 20 countries in Europe, Asia, the Middle East and South America. The company expects to announce shortly the initiation of patient enrollment in a major clinical study of their intravascular OCT system in the U.S.
In November, OCT was recognized in a special meeting article in the European Heart Journal in which the European Society of Cardiology and the European Association for Percutaneous Cardiovascular Interventions together with European regulatory bodies recommended OCT as a modality for assessing stent coverage and neointima formation in clinical studies designed to support regulatory submissions for new stents in Europe.
For more information: www.lightlabimaging.com